Ireland· IE-PA-EU/1/15/1075/001-004
Feraccru 30 mg hard capsules
A ferric maltol product containing ferric maltol, registered in Ireland by Norgine B.V.. The same ATC class is registered in 12 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Ferric maltol is registered in 12 of 19 countries.
Countries holding a registration under ATC B03AB10 (ferric maltol), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Ferric maltol · ATC B03AB10
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Ferric maltol
- Manufacturer
- Norgine B.V.
- Country
- Ireland (IE)
- ATC code
- B03AB10
- ATC class
- Ferric maltol
- Defined daily dose
- 60 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/15/1075/001-004
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ferric maltol in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFERACCRUNorgine B.V., Amsterdam
- SpainFERACCRU 30 MG CAPSULAS DURASNorgine B.V.
- FinlandFeraccruNorgine B.V.
- United KingdomFeraccru 30mg capsulesNorgine Pharmaceuticals Ltd
- IcelandFeraccruNorgine B.V.
- NorwayFeraccruNorgine B.V.
- SwedenFeraccru 30 mg Kapsel, hårdNorgine BV
- BelgiumFeraccru 30 mgNorgine
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- United Kingdom (Northern Ireland) · Feraccru
- Iceland · Feraccru
- Liechtenstein · Feraccru
- Norway · Feraccru
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/94f1b811-a0f1-49c5-8965-b651340d845a GET /v1/drugs/94f1b811-a0f1-49c5-8965-b651340d845a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"B03AB",
"B03AB10"
],
"strength": null,
"pa_number": "EU/1/15/1075/001-004",
"substances": [
"Ferric maltol"
],
"legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "18/02/2016",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about ferric maltol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.